Harbor Capital Advisors Inc. Increases Holdings in AdaptHealth Corp. (NASDAQ:AHCO)

Harbor Capital Advisors Inc. raised its stake in AdaptHealth Corp. (NASDAQ:AHCO) by 5.5% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 474,722 shares of the company’s stock after acquiring an additional 24,882 shares during the period. Harbor Capital Advisors Inc. owned approximately 0.35% of AdaptHealth worth $4,519,000 as of its most recent SEC filing.

Several other large investors have also recently modified their holdings of the stock. Rhumbline Advisers increased its stake in AdaptHealth by 1.3% during the 2nd quarter. Rhumbline Advisers now owns 271,033 shares of the company’s stock valued at $2,710,000 after purchasing an additional 3,498 shares in the last quarter. Los Angeles Capital Management LLC bought a new position in AdaptHealth in the 2nd quarter valued at approximately $151,000. Quest Partners LLC boosted its stake in AdaptHealth by 11,522.7% during the 2nd quarter. Quest Partners LLC now owns 10,228 shares of the company’s stock valued at $102,000 after purchasing an additional 10,140 shares during the last quarter. Texas Permanent School Fund Corp raised its stake in shares of AdaptHealth by 11.9% in the second quarter. Texas Permanent School Fund Corp now owns 79,704 shares of the company’s stock worth $797,000 after purchasing an additional 8,503 shares during the last quarter. Finally, American Century Companies Inc. lifted its holdings in shares of AdaptHealth by 25.0% during the second quarter. American Century Companies Inc. now owns 116,122 shares of the company’s stock valued at $1,161,000 after purchasing an additional 23,215 shares in the last quarter. Hedge funds and other institutional investors own 82.67% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts have recently weighed in on the stock. UBS Group decreased their price objective on shares of AdaptHealth from $13.00 to $12.00 and set a “buy” rating for the company in a report on Wednesday, November 6th. Truist Financial lowered their price target on AdaptHealth from $13.00 to $12.00 and set a “buy” rating on the stock in a report on Friday, November 15th. Canaccord Genuity Group cut their price objective on AdaptHealth from $14.00 to $13.00 and set a “buy” rating for the company in a report on Wednesday, November 6th. Robert W. Baird lowered their target price on AdaptHealth from $16.00 to $14.00 and set an “outperform” rating on the stock in a report on Wednesday, November 6th. Finally, Royal Bank of Canada reduced their price target on shares of AdaptHealth from $13.00 to $11.00 and set an “outperform” rating for the company in a research report on Tuesday, November 19th. Five equities research analysts have rated the stock with a buy rating, According to data from MarketBeat, AdaptHealth currently has a consensus rating of “Buy” and a consensus target price of $12.40.

AdaptHealth Stock Performance

Shares of AHCO opened at $10.14 on Friday. AdaptHealth Corp. has a 52 week low of $6.46 and a 52 week high of $11.90. The company has a quick ratio of 1.00, a current ratio of 1.24 and a debt-to-equity ratio of 1.34. The stock has a market cap of $1.36 billion, a price-to-earnings ratio of -6.15, a PEG ratio of 1.36 and a beta of 1.09. The business has a 50-day simple moving average of $9.86 and a two-hundred day simple moving average of $10.32.

AdaptHealth (NASDAQ:AHCO) last announced its quarterly earnings data on Tuesday, November 5th. The company reported $0.15 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.17 by ($0.02). The firm had revenue of $805.90 million during the quarter, compared to analysts’ expectations of $809.32 million. AdaptHealth had a positive return on equity of 9.62% and a negative net margin of 6.57%. The business’s revenue for the quarter was up .2% on a year-over-year basis. During the same period last year, the company earned $0.19 earnings per share. On average, analysts expect that AdaptHealth Corp. will post 0.88 EPS for the current year.

About AdaptHealth

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.